PTP1B and TCPTP – nonredundant phosphatases in insulin signaling and glucose homeostasis

Insulin resistance is a key pathological feature of type 2 diabetes and is characterized by defects in signaling by the insulin receptor (IR) protein tyrosine kinase. The inhibition of protein tyrosine phosphatases (PTPs) that antagonize IR signaling may provide a means for enhancing the insulin response and alleviating insulin resistance. The prototypic phosphotyrosine‐specific phosphatase PTP1B dephosphorylates the IR and attenuates insulin signaling in muscle and liver. Mice that are deficient for PTP1B exhibit improved glucose homeostasis in diet and genetic models of insulin resistance and type 2 diabetes. The phosphatase TCPTP shares 72% catalytic domain sequence identity with PTP1B and has also been implicated in IR regulation. Despite their high degree of similarity, PTP1B and TCPTP act together in vitro and in vivo to regulate insulin signaling and glucose homeostasis. This review highlights their capacity to act specifically and nonredundantly in cellular signaling, describes their roles in IR regulation and glucose homeostasis, and discusses their potential as drug targets for the enhancement of IR phosphorylation and insulin sensitivity in type 2 diabetes.

[1]  S. Akira,et al.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. , 2006, Cell metabolism.

[2]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[3]  J. Chernoff,et al.  Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin* , 1997, The Journal of Biological Chemistry.

[4]  M. Tremblay,et al.  TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. , 2007, Blood.

[5]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998, Molecular and Cellular Biology.

[6]  D. Barford,et al.  Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Newell,et al.  T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. , 2004, Blood.

[8]  B. Neel,et al.  Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. , 2011, Cell metabolism.

[9]  Nicholette D. Palmer,et al.  Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. , 2004, Diabetes.

[10]  M. White,et al.  Insulin signaling meets mitochondria in metabolism , 2010, Trends in Endocrinology & Metabolism.

[11]  Dan R. Littman,et al.  PKC-θ knockout mice are protected from fat-induced insulin resistance , 2004 .

[12]  R. Zechner,et al.  Brain insulin controls adipose tissue lipolysis and lipogenesis. , 2011, Cell metabolism.

[13]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[14]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[15]  B. Neel,et al.  The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence , 1992, Cell.

[16]  Yuebo Zhang,et al.  Berberine inhibits PTP1B activity and mimics insulin action. , 2010, Biochemical and biophysical research communications.

[17]  Jerrold M. Olefsky,et al.  Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.

[18]  J. Chernoff,et al.  Transformation Suppression by Protein Tyrosine Phosphatase 1B Requires a Functional SH3 Ligand , 1998, Molecular and Cellular Biology.

[19]  M. Tremblay,et al.  Coordinated action of protein tyrosine phosphatases in insulin signal transduction. , 2002, European journal of biochemistry.

[20]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[21]  C. Bogardus,et al.  Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. , 1990, The American journal of physiology.

[22]  C. Kahn,et al.  Bi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor* , 2003, Journal of Biological Chemistry.

[23]  C. Kahn,et al.  Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation , 2004, Molecular and Cellular Biology.

[24]  T. Tiganis,et al.  DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. , 2008, Cancer cell.

[25]  E. Asante-Appiah,et al.  Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells* , 2004, Journal of Biological Chemistry.

[26]  A. Bennett,et al.  Protein tyrosine phosphatase function: the substrate perspective. , 2007, The Biochemical journal.

[27]  F. Haj,et al.  Regulation of Brown Fat Adipogenesis by Protein Tyrosine Phosphatase 1B , 2011, PloS one.

[28]  M. Tremblay,et al.  The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3 , 2002, Current Biology.

[29]  M. Tremblay,et al.  Regulation of the Met Receptor-tyrosine Kinase by the Protein-tyrosine Phosphatase 1B and T-cell Phosphatase* , 2008, Journal of Biological Chemistry.

[30]  B. Goldstein.  Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[31]  B. Kennedy,et al.  PTP1B-dependent insulin receptor phosphorylation/residency in the endocytic recycling compartment of CHO-IR cells. , 2006, Biochemical pharmacology.

[32]  D. Lawrence,et al.  Cellular effects of small molecule PTP1B inhibitors on insulin signaling. , 2003, Biochemistry.

[33]  S. Arkinstall,et al.  Identification of Tyrosine Phosphatases That Dephosphorylate the Insulin Receptor , 2000, The Journal of Biological Chemistry.

[34]  G. Shulman,et al.  PKC-theta knockout mice are protected from fat-induced insulin resistance. , 2004, The Journal of clinical investigation.

[35]  N. Tonks,et al.  Regulation of Insulin Signaling through Reversible Oxidation of the Protein-tyrosine Phosphatases TC45 and PTP1B* , 2004, Journal of Biological Chemistry.

[36]  C. Kahn,et al.  Protein-tyrosine Phosphatase 1B Deficiency Reduces Insulin Resistance and the Diabetic Phenotype in Mice with Polygenic Insulin Resistance* , 2007, Journal of Biological Chemistry.

[37]  G. Dohm,et al.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.

[38]  P. Drake,et al.  Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesis , 1995, Molecular and Cellular Biochemistry.

[39]  M. Bentires-Alj,et al.  Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress. , 2011, The Biochemical journal.

[40]  M. White,et al.  The IRS-signalling system: A network of docking proteins that mediate insulin action , 1998, Molecular and Cellular Biochemistry.

[41]  R. DeFronzo,et al.  Pathogenesis of Insulin Resistance in Skeletal Muscle , 2010, Journal of biomedicine & biotechnology.

[42]  J. Brüning,et al.  Central insulin action in energy and glucose homeostasis. , 2006, The Journal of clinical investigation.

[43]  N. Tonks,et al.  Characterization of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[44]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[45]  T. Tiganis.  Reactive oxygen species and insulin resistance: the good, the bad and the ugly. , 2011, Trends in pharmacological sciences.

[46]  B. Kemp,et al.  Cellular Stress Regulates the Nucleocytoplasmic Distribution of the Protein-tyrosine Phosphatase TCPTP* , 2001, The Journal of Biological Chemistry.

[47]  B. Kemp,et al.  The Protein-tyrosine Phosphatase TCPTP Regulates Epidermal Growth Factor Receptor-mediated and Phosphatidylinositol 3-Kinase-dependent Signaling* , 1999, The Journal of Biological Chemistry.

[48]  B. Neel,et al.  Neuronal PTP1B regulates body weight, adiposity and leptin action , 2006, Nature Medicine.

[49]  J. Zierath,et al.  Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. , 2000, Diabetes.

[50]  I. Lossos,et al.  PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. , 2008, Blood.

[51]  B. Neel,et al.  Liver-Specific Deletion of Protein-Tyrosine Phosphatase 1 B ( PTP 1 B ) Improves Metabolic Syndrome and Attenuates Diet-Induced ER Stress , 2008 .

[52]  B. Neel,et al.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice , 2012, Diabetologia.

[53]  N. Tonks,et al.  Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition , 1997, Oncogene.

[54]  E. Asante-Appiah,et al.  Protein tyrosine phosphatases: the quest for negative regulators of insulin action. , 2003, American journal of physiology. Endocrinology and metabolism.

[55]  J. Olefsky,et al.  Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor , 1996, Diabetes.

[56]  F. Haj,et al.  Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. , 2004, Diabetes.

[57]  J. Waring,et al.  Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. , 2002, Diabetes.

[58]  Tetsuya Yamamoto,et al.  The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. , 2002, Biochemical and biophysical research communications.

[59]  I. Lossos,et al.  PTP 1 B is a negative regulator of interleukin 4 – induced STAT 6 signaling , 2008 .

[60]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[61]  N. Tonks,et al.  Purification of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[62]  D. Barford,et al.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. , 2000, Molecular cell.

[63]  J. Waring,et al.  PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[65]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[66]  Jan Nedergaard,et al.  Brown adipose tissue: function and physiological significance. , 2004, Physiological reviews.

[67]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p 52 Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998 .

[68]  Peter J Verveer,et al.  Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum , 2002, Science.

[69]  Á. Valverde,et al.  Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice , 2009, Diabetes.

[70]  B. Neel,et al.  Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo* , 2008, Journal of Biological Chemistry.

[71]  W. Cavenee,et al.  The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor* , 2001, The Journal of Biological Chemistry.

[72]  J. Chernoff,et al.  Down-regulation of Insulin Signaling by Protein-tyrosine Phosphatase 1B Is Mediated by an N-terminal Binding Region* , 2000, The Journal of Biological Chemistry.

[73]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[74]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[75]  Ralph A. DeFronzo,et al.  From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.

[76]  Nicholette D. Palmer,et al.  Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. , 2004, Diabetes.

[77]  A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. , 2002, Molecular endocrinology.

[78]  K. Morino,et al.  Protein-tyrosine Phosphatase-1B Negatively Regulates Insulin Signaling in L6 Myocytes and Fao Hepatoma Cells* , 2001, The Journal of Biological Chemistry.

[79]  D. James,et al.  Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. , 2008, Cell metabolism.

[80]  I. Lossos,et al.  T-Cell Protein Tyrosine Phosphatase, Distinctively Expressed in Activated-B-Cell-Like Diffuse Large B-Cell Lymphomas, Is the Nuclear Phosphatase of STAT6 , 2007, Molecular and Cellular Biology.

[81]  F. Haj,et al.  Differential Regulation of Endoplasmic Reticulum Stress by Protein Tyrosine Phosphatase 1B and T Cell Protein Tyrosine Phosphatase* , 2011, The Journal of Biological Chemistry.

[82]  F. Haj,et al.  Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP , 2005, Molecular and Cellular Biology.

[83]  B. Neel,et al.  TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. , 2011, Genes & development.

[84]  M. Tremblay,et al.  T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis , 2010, Diabetes.

[85]  Q. Zhai,et al.  SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. , 2007, Cell metabolism.

[86]  M. Tremblay,et al.  Deletion of Protein Tyrosine Phosphatase 1b Improves Peripheral Insulin Resistance and Vascular Function in Obese, Leptin-Resistant Mice via Reduced Oxidant Tone , 2009, Circulation research.

[87]  J. Silverman,et al.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. , 1986, The Journal of clinical investigation.

[88]  M. Quon,et al.  Protein-tyrosine Phosphatases PTP1B and Syp Are Modulators of Insulin-stimulated Translocation of GLUT4 in Transfected Rat Adipose Cells* , 1997, The Journal of Biological Chemistry.

[89]  Jason K. Kim,et al.  Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance , 2009, Molecular and Cellular Biology.

[90]  M. Tremblay,et al.  T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. , 2011, The Journal of clinical investigation.

[91]  M. Quon,et al.  A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. , 1999, Biochemistry.

[92]  E. Krebs,et al.  cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Meyerovitch,et al.  Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*) , 1995, The Journal of Biological Chemistry.

[94]  Heung-Chin Cheng,et al.  Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530 , 1999, Oncogene.

[95]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[96]  Á. Valverde,et al.  Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli. , 2010, Cellular signalling.

[97]  B. Neel,et al.  Liver-Specific Deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) Improves Metabolic Syndrome and Attenuates Diet-Induced Endoplasmic Reticulum Stress , 2009, Diabetes.

[98]  N. Tonks,et al.  Regulation of Insulin Receptor Signaling by the Protein Tyrosine Phosphatase TCPTP , 2003, Molecular and Cellular Biology.

[99]  Chao‐Jun Li,et al.  Cellular Inhibition of Protein Tyrosine Phosphatase 1B by Uncharged Thioxothiazolidinone Derivatives , 2007, Chembiochem : a European journal of chemical biology.

[100]  Cisca Wijmenga,et al.  Shared and distinct genetic variants in type 1 diabetes and celiac disease. , 2008, The New England journal of medicine.

[101]  J. Chernoff,et al.  Interaction of protein tyrosine phosphatase (PTP) 1B with its substrates is influenced by two distinct binding domains. , 2002, The Biochemical journal.

[102]  A. Rajala,et al.  Phosphorylated Grb14 Is an Endogenous Inhibitor of Retinal Protein Tyrosine Phosphatase 1B, and Light-Dependent Activation of Src Phosphorylates Grb14 , 2011, Molecular and Cellular Biology.

[103]  A. Mora,et al.  Prevention of steatosis by hepatic JNK1. , 2009, Cell metabolism.

[104]  J. Chernoff,et al.  Protein-tyrosine Phosphatase 1B Mediates the Effects of Insulin on the Actin Cytoskeleton in Immortalized Fibroblasts* , 2003, Journal of Biological Chemistry.

[105]  B. Neel,et al.  Improved Glucose Homeostasis in Mice with Muscle-Specific Deletion of Protein-Tyrosine Phosphatase 1B , 2007, Molecular and Cellular Biology.

[106]  B. Kennedy,et al.  Protein tyrosine phosphatase-1B in diabetes. , 2000, Biochemical pharmacology.

[107]  R. Ulrich,et al.  Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. , 2003, Diabetes.

[108]  T. Pellinen,et al.  Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP , 2005, Nature Cell Biology.

[109]  D. Barford,et al.  TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.

[110]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[111]  G. Shulman,et al.  Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action* , 2004, Journal of Biological Chemistry.

[112]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[113]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[114]  S. Shoelson,et al.  Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor , 1996, Cell.

[115]  Sheng Zhang,et al.  PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. , 2007, Drug discovery today.

[116]  P. Drake,et al.  Insulin receptor-associated protein tyrosine phosphatase(s): Role in insulin action , 1998, Molecular and Cellular Biochemistry.

[117]  E. Krebs,et al.  Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[118]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[119]  Tao Xu,et al.  Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. , 2007, Cell metabolism.

[120]  J. ten Hoeve,et al.  Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase , 2002, Molecular and Cellular Biology.

[121]  B. Goldstein,et al.  Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. , 1995, The American journal of physiology.

[122]  D. Hill,et al.  Direct Binding of the Proline-rich Region of Protein Tyrosine Phosphatase 1B to the Src Homology 3 Domain of p130Cas* , 1996, The Journal of Biological Chemistry.

[123]  M. Tremblay,et al.  Selective regulation of tumor necrosis factor–induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase , 2005, Nature Immunology.

[124]  B. Goldstein,et al.  Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases , 1998, Molecular and Cellular Biochemistry.

[125]  C. Heldin,et al.  Site-Selective Regulation of Platelet-Derived Growth Factor β Receptor Tyrosine Phosphorylation by T-Cell Protein Tyrosine Phosphatase , 2004, Molecular and Cellular Biology.

[126]  J. Auwerx,et al.  Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. , 2011, Cell metabolism.

[127]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[128]  B. Neel,et al.  Overexpression of Protein-tyrosine Phosphatase-1B in Adipocytes Inhibits Insulin-stimulated Phosphoinositide 3-Kinase Activity without Altering Glucose Transport or Akt/Protein Kinase B Activation* , 2000, The Journal of Biological Chemistry.

[129]  B. Kennedy,et al.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. , 2002, Developmental cell.

[130]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[131]  F. Haj,et al.  Liver-specific Protein-tyrosine Phosphatase 1B (PTP1B) Re-expression Alters Glucose Homeostasis of PTP1B–/–Mice* , 2005, Journal of Biological Chemistry.

[132]  G. Rogler,et al.  Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells , 2010, Gut.

[133]  R. DeFronzo,et al.  Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. , 2001, Diabetes.

[134]  K. Kaestner,et al.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). , 2001, Science.

[135]  J. Carvalheira,et al.  Reduction of Hypothalamic Protein Tyrosine Phosphatase Improves Insulin and Leptin Resistance in Diet-induced Obese Rats , 2022 .

[136]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[137]  P. Almgren,et al.  A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance. , 2002, American journal of human genetics.

[138]  Sven Branner,et al.  Structure Determination of T Cell Protein-tyrosine Phosphatase* , 2002, The Journal of Biological Chemistry.

[139]  B. Larijani,et al.  Protein Tyrosine Phosphatase-1B (PTP-1B) Knockdown Improves Palmitate-Induced Insulin Resistance in C2C12 Skeletal Muscle Cells , 2010, Lipids.

[140]  Young-Bum Kim,et al.  PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.